Back to top

Image: Bigstock

Cardinal Health Inc.

Read MoreHide Full Article

Cardinal Health’s Specialty business gained a number of Pharmaceutical Distribution customers. The company is on track to deliver targeted annualized cost savings of $100 million in fiscal 2019 and in excess of $200 million by the end of fiscal year 2020. On the negative side, despite growth in business, profits in the Pharmaceutical segment were hurt by generic pharmaceutical pricing. Huge investments in Pharmaceutical IT platform and lackluster generics performance are likely to mar Cardinal Health’s operational efficiencies in the upcoming quarters. Intense competition and customer concentration are other bottlenecks. Recently, the company closed the divestiture of Cardinal Health China distribution. Cardinal Health underperformed its industry in a year's time.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Cardinal Health, Inc. (CAH) - free report >>

Published in